# PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

> **NCT04557501** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 800 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PSMA PET/CT guided intensification of therapy
- **OTHER:** Control Arm

## Key facts

- **NCT ID:** NCT04557501
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-06
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557501, "PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04557501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*